norethindrone and Venous Thromboembolism

norethindrone has been researched along with Venous Thromboembolism in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	4 (66.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Cockrum, RH; Cohen, KS; Ham, SA; Snow, SG; Soo, J	1
Bergendal, A; Hirschberg, AL; Kieler, H; Kocoska-Maras, L; Sundström, A	1
Fenton, A; Panay, N	1
Hall, KS; Schwarz, EB; Trussell, J	1
Mansour, D	1
Casey, CL; Murray, CA	1

Reviews

1 review(s) available for norethindrone and Venous Thromboembolism

Article	Year
HT update: spotlight on estradiol/norethindrone acetate combination therapy. Clinical interventions in aging, 2008, Volume: 3, Issue:1 Topics: Bone Density; Breast Neoplasms; Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Memory; Norethindrone; Norethindrone Acetate; Risk Assessment; Stroke; Venous Thromboembolism	2008

Article

Year

HT update: spotlight on estradiol/norethindrone acetate combination therapy.

Clinical interventions in aging, 2008, Volume: 3, Issue:1

Topics: Bone Density; Breast Neoplasms; Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Memory; Norethindrone; Norethindrone Acetate; Risk Assessment; Stroke; Venous Thromboembolism

2008

Other Studies

5 other study(ies) available for norethindrone and Venous Thromboembolism

Article	Year
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstetrics and gynecology, 2022, 09-01, Volume: 140, Issue:3 Topics: Adult; Case-Control Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Venous Thromboembolism	2022
Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration. Menopause (New York, N.Y.), 2016, Volume: 23, Issue:6 Topics: Administration, Cutaneous; Administration, Oral; Case-Control Studies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Odds Ratio; Perimenopause; Postmenopause; Progestins; Risk Factors; Sweden; Vagina; Venous Thromboembolism	2016
Alternative regimens for endometrial protection ? Where are we now? Climacteric : the journal of the International Menopause Society, 2011, Volume: 14, Issue:6 Topics: Androstenes; Antihypertensive Agents; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Hypertension; Norethindrone; Postmenopause; Progesterone; Uterine Hemorrhage; Venous Thromboembolism	2011
Progestin-only contraceptive pill use among women in the United States. Contraception, 2012, Volume: 86, Issue:6 Topics: Adolescent; Adult; Breast Feeding; Contraception Behavior; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Family Characteristics; Female; Health Surveys; Humans; Norethindrone; Parity; Postpartum Period; Pregnancy; Progesterone Congeners; Risk Factors; United States; Venous Thromboembolism; Young Adult	2012
Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolism. The journal of family planning and reproductive health care, 2012, Volume: 38, Issue:3 Topics: Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Female; Humans; Norethindrone; Risk Factors; Venous Thromboembolism	2012